In addition to oncogenic fusions, germline mutations, such as activating point mutations, in RET are also associated with neoplasia and tumorigenesis, namely in multiple endocrine neoplasia type 2 (MEN2; described in 4.2). The gene discussed is RET; the disease is neoplasm.